Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation
Clinical trial NCT01483183 · TERMINATED
Trial details
- NCT number
- NCT01483183
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2015-10-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.